However, they were less effective against malaria parasites than two widely used antimalarial drugs
, chloroquine ([IC.
Induction of multiple pleiotropic drug resistance genes in yeast engineered to produce an increased level of antimalarial drug
precursor, artemisinic acid.
The battle against malaria continues to face daunting challenges mounted by drug resistance to most antimalarial drugs
, insecticide resistance by mosquitoes and other climatic and socio-cultural factors (3).
discovery: efficacy models for compounds screening.
7,8) This illustrates the importance of clinical and laboratory monitoring of antimalarial drug
resistance in the parasite, and the entomological monitoring of vectors and insecticide resistance.
Diabetes developed in 70% of the subjects who had never taken the antimalarial drug
, compared with only 48% of those who had ever taken it.
Tom Coburn and others, it emerged that in fiscal year 2004, USMD spent just 5 percent of its malaria budget on antimalarial drugs
Our understanding of the molecular mechanisms of antimalarial drug
resistance developed by P.
This is why we are so enthusiastic about KAE609; it is the first new antimalarial drug
candidate with a completely novel mechanism of action to reach Phase 2 clinical development in over 20 years.
The most frequently cited article was "Qinghaosu (Artemisinin): An antimalarial drug
from China" written in 1985 by Klayman D.
Therefore, there is a need to closely monitor the changing patterns of antimalarial drug
susceptibility, cross-resistance and also investigate new potent antimalarial drugs
Artemisinin is considered a potent antimalarial drug
, even against chloroquine- and quinine-resistant Plasmodium falciparum and other malaria-causing parasites.
coli bacteria that pump out artemisinin, a potent antimalarial drug
typically harvested from wormwood plants.
Warnings and contraindications have been added to the labeling for the antimalarial drug
mefloquine to reflect reports of psychiatric effects in people who have taken the drug.
Carola Hunte has succeeded in describing how the antimalarial drug
atovaquone binds to its target protein.